CONSUN PHARMAC.GR.HD -10 Cash Flow Reinvestment Rate
CONSUN PHARMAC.GR.HD -10 cash flow reinvestment rate. CONSUN PHARMAC.GR.HD -10 (C1P) has a Cash Flow Reinvestment Rate of 1.80x as of December 2025, reinvesting €2.18 Billion (capex €68.48 Million plus investments €-2.11 Billion) from operating cash flow of €1.21 Billion. Explore C1P debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of CONSUN PHARMAC.GR.HD -10 (2021–2025)
Cash flow reinvestment rate of CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. Historical reinvestment intensity for CONSUN PHARMAC.GR.HD -10 across 5 annual periods. Explore capital reinvestment ratio of CONSUN PHARMAC.GR.HD -10 to see what proportion of operating cash flow is directed to capital expenditures.
CONSUN PHARMAC.GR.HD -10 Cash Flow Reinvestment Rate by Year (2021–2025)
CONSUN PHARMAC.GR.HD -10 cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for CONSUN PHARMAC.GR.HD -10. For the full cash flow conversion analysis, see CONSUN PHARMAC.GR.HD -10 operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.80x | €2.18 Billion | €1.21 Billion | €68.48 Million | ▲ +708.6% |
| 2024 | 0.22x | €242.06 Million | €1.09 Billion | €109.00 Million | ▼ -39.4% |
| 2023 | 0.37x | €300.83 Million | €818.97 Million | €52.56 Million | ▼ -16.6% |
| 2022 | 0.44x | €417.26 Million | €947.68 Million | €51.59 Million | ▼ -2.7% |
| 2021 | 0.45x | €328.25 Million | €725.54 Million | €98.25 Million | — |